Lv1
30 积分 2024-09-10 加入
TERT promoter mutations are associated with poor prognosis in cutaneous squamous cell carcinoma
12天前
已完结
Sirolimus for Secondary Prevention of Cutaneous Squamous Cell Carcinoma in Kidney Transplant Recipients: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
26天前
已完结
PLOD2 Promotes Cutaneous Squamous Cell Carcinoma Progression in Association With STAT3‐Related ERK and AKT Pathways
26天前
已完结
Targeting the PI3K pathway in cancer: are we making headway?
27天前
已完结
Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer
29天前
已完结
Road to ABT‐869: A Multitargeted Receptor Tyrosine Kinase Inhibitor
29天前
已完结
Development of a MEK inhibitor, NFX-179, as a chemoprevention agent for squamous cell carcinoma
1个月前
已完结
FGFR Inhibition Overcomes Resistance to EGFR-targeted Therapy in Epithelial-like Cutaneous Carcinoma
1个月前
已完结
LPCAT1 Promotes Cutaneous Squamous Cell Carcinoma via EGFR-Mediated Protein Kinase B/p38MAPK Signaling Pathways
1个月前
已完结
Avelumab plus cetuximab in patients with unresectable stage III or IV cutaneous squamous cell carcinoma: clinical activity and safety results from AliCe, a single-arm multicentre phase II DeCOG trial
1个月前
已完结
皖公网安备34019202002308
